Tectonic Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.4M Buy
432,091
+31,491
+8% +$824K 0.5% 61
2026
Q1
$11.2M Buy
400,600
+25,422
+7% +$677K 0.59% 53
2025
Q4
$9.34M Buy
375,178
+26,754
+8% +$675K 0.49% 63
2025
Q3
$8.88M Buy
348,424
+49,737
+17% +$1.23M 0.48% 65
2025
Q2
$7.24M Buy
298,687
+54,068
+22% +$1.26M 0.42% 67
2025
Q1
$6.2M Buy
244,619
+20,933
+9% +$548K 0.39% 69
2024
Q4
$5.93M Buy
223,686
+42,570
+24% +$1.15M 0.39% 70
2024
Q3
$5.24M Buy
181,116
+30,320
+20% +$884K 0.34% 71
2024
Q2
$4.22M Buy
150,796
+20,292
+16% +$559K 0.3% 75
2024
Q1
$3.62M Buy
130,504
+3,571
+3% +$99.1K 0.28% 76
2023
Q4
$3.65M Buy
126,933
+19,173
+18% +$580K 0.31% 72
2023
Q3
$3.57M Buy
107,760
+22,143
+26% +$783K 0.34% 62
2023
Q2
$3.14M Buy
85,617
+11,965
+16% +$466K 0.39% 63
2023
Q1
$3.01M Buy
73,652
+16,035
+28% +$693K 0.41% 61
2022
Q4
$2.95M Buy
57,617
+8,930
+18% +$428K 0.46% 45
2022
Q3
$2.13M Buy
48,687
+8,277
+20% +$402K 0.39% 52
2022
Q2
$2.12M Buy
40,410
+6,510
+19% +$332K 0.39% 49
2022
Q1
$1.75M Sell
33,900
-7,972
-19% -$414K 0.3% 54
2021
Q4
$2.47M Buy
41,872
+3,693
+10% +$183K 0.44% 40
2021
Q3
$1.64M Buy
38,179
+1,116
+3% +$49.4K 0.32% 50
2021
Q2
$1.45M Buy
37,063
+4,788
+15% +$186K 0.3% 52
2021
Q1
$1.17M Buy
32,275
+3,722
+13% +$132K 0.29% 60
2020
Q4
$1.05M Buy
+28,553
New +$1.05M 0.29% 62

Other funds holding PFE

Tectonic Advisors's PFE Position: Q2 2026 in Review

Tectonic Advisors increased its Pfizer (PFE) stake by 7.9% in Q2 2026, buying an estimated $824K and bringing the position to 432,091 shares worth $10.4M. The position accounts for 0.5% of the portfolio, ranked #61.

Tectonic Advisors first reported a position in PFE in Q4 2020 and has held it in 23 quarters since. The position peaked at $11.2M in Q1 2026. 546 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Tectonic Advisors held 432,091 shares of Pfizer worth $10.4M as of Q2 2026.
  • Tectonic Advisors bought 31,491 Pfizer shares in Q2 2026, an estimated $824K.
  • Pfizer made up 0.5% of Tectonic Advisors's portfolio in Q2 2026, its #61 holding.
  • Tectonic Advisors first reported a position in Pfizer in Q4 2020 and has held it in 23 quarters since.
  • Tectonic Advisors's Pfizer position peaked at $11.2M in Q1 2026.
  • 546 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Tectonic Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.